Wegovy & Mounjaro β How GLP-1 Tricks Your Brain
The scientific mechanism behind appetite disappearing with one injection
The most talked-about drugs of 2023-2025: Wegovy and Mounjaro. From Hollywood celebrities to everyday people β "inject it and lose weight." Clinical trials showed 15-25% body weight reduction. How is this possible?
What Is GLP-1?
GLP-1 (Glucagon-Like Peptide-1) is a hormone released by the small intestine after eating.
Natural functions:
Stimulates insulin secretion β blood sugar control
Slows gastric emptying β food stays in stomach longer β prolonged fullness
Sends satiety signals to hypothalamus β appetite suppression
Suppresses glucagon
Problem: natural GLP-1's half-life is ~2 minutes. Gets destroyed by DPP-4 enzyme almost immediately.
Wegovy (Semaglutide)
By Novo Nordisk (Denmark). Same molecule as diabetes drug Ozempic, different dosage.
Semaglutide is 94% identical to natural GLP-1 but engineered to resist DPP-4 breakdown. Half-life: ~7 days. Once-weekly injection.
- Delayed gastric emptying: Eat less, feel full longer
- Direct hypothalamus action: Continuous "full" signal to appetite center
- Reward circuit suppression: Food cravings diminish
- Insulin boost: Blood sugar management bonus
STEP 1 trial: -14.9% body weight (vs -2.4% placebo) over 68 weeks.
Mounjaro (Tirzepatide)
By Eli Lilly (US). Key difference from Wegovy: dual-action.
GLP-1 receptor agonist (same as Wegovy)
GIP receptor agonist (additional)
GLP-1 + GIP synergy = stronger appetite suppression + enhanced fat metabolism.
SURMOUNT-1 trial: -20.9% body weight at highest dose. 100kg β 79kg without surgery. Unprecedented in medical history.
Side Effects & Concerns
| Effect | Frequency | Note |
|---|---|---|
| Nausea/vomiting | Very common (30-40%) | From slowed gastric emptying |
| Muscle loss | Concerning | 25-40% of weight lost is muscle |
| "Ozempic face" | Visible | Facial sagging from rapid weight loss |
| Pancreatitis | Rare | Stop immediately if severe abdominal pain |
Biggest controversy: muscle loss and the fact that stopping the drug means regaining ~2/3 of lost weight within a year.
How It Works
GLP-1 = satiety hormone from small intestine. Natural half-life 2min, drug version 7 days
Wegovy (semaglutide): GLP-1 only. -14.9% body weight over 68 weeks
Mounjaro (tirzepatide): GLP-1 + GIP dual-action. -20.9% over 72 weeks (stronger than Wegovy)
Mechanism: delayed gastric emptying + hypothalamus satiety + reward circuit suppression